(Q39920490)

15 September 2017

1 reference

reason for preferred rank

title

Medical treatment of angina pectoris VIII. Miscellaneous antianginal drugs (English)

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

5 February 2023

Medical treatment of angina pectoris. 8. Miscellaneous antianginal drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4564946

Cardiology and cardiovascular medicine

5 February 2023

main subject

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

5 February 2023

author name string

W. S. Aronow

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4564946

5 February 2023

language of work or name

English

0 references

publication date

1 January 1973

1 reference

full work available at URL

15 September 2017

https://api.elsevier.com/content/article/PII:000287037390536X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

https://api.elsevier.com/content/article/PII:000287037390536X?httpAccept=text/plain

5 February 2023

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

5 February 2023

published in

American Heart Journal

1 reference

15 September 2017

volume

85

1 reference

15 September 2017

issue

1

1 reference

15 September 2017

page(s)

132-137

1 reference

Medical treatment of angina pectoris III. Pharmacology of sublingual nitrites as antianginal drugs

15 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

The medical treatment of angina pectoris V. Long-acting nitrites as antianginal drugs

5 February 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

Evaluation of dipyridamole (Persantin)

5 February 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

Controlled double-blind trial of "persantin" in treatment of angina pectoris

5 February 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

Studies with a new coronary vasodilator drug: Persantin

5 February 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

Experimental and clinical observations on 2,6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d) pyrimidine (Persantin)

5 February 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

LONG TERM DIPYRIDAMOLE THERAPY OF ANGINA PECTORIS

5 February 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

A re-evaluation of papaverine in the treatment of angina pectoris

5 February 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

Ethaverine in the treatment of angina pectoris

5 February 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

A double-blind, double cross-over trial of prenylamine in angina pectoris

5 February 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

Clinical evaluation of verapamil in angina pectoris.

5 February 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

Pharmacology of a new antianginal drug: perhexiline. I. Coronary circulation and myocardial metabolism

5 February 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

Perhexilene maleate in treatment of angina pectoris

5 February 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

A CLINICAL AND HEMODYNAMIC ANALYSIS OF FACTORS LIMITING THE CARDIAC PERFORMANCE IN PATIENTS WITH CORONARY HEART DISEASE

5 February 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

Failure of acute digitalization to influence exercise tolerance in angina pectoris

5 February 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

The Effect of Acute Digitalization on the Hemodynamic Response to Exercise in Coronary Artery Disease

5 February 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

Effects of Ouabain on the Left Ventricular Response to Exercise in Patients with Angina Pectoris

5 February 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

Alcohol in the treatment of angina pectoris

5 February 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

Haemodynamic effects of ethyl alcohol in patients with coronary heart disease

5 February 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

The effect of ingestion of ethyl alcohol, wine and beer on the myocardium of mice.

5 February 2023

28

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

Tobacco: A Precipitating Factor in Angina Pectoris

5 February 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

The effect of low-nicotine cigarettes on angina pectoris

5 February 2023

31

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

Heart rate and carbon monoxide level after smoking high-, low-, and non-nicotine cigarettes. A study in male patients with angina pectoris

5 February 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

Carboxyhemoglobin caused by smoking nonnicotine cigarettes. Effects in angina pectoris

5 February 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90536-X

5 February 2023

Identifiers

1 reference

15 September 2017

1 reference